Literature DB >> 33413619

Conceptualizing the effects of the COVID-19 pandemic on people with opioid use disorder: an application of the social ecological model.

Ethan Cowan1,2, Maria R Khan3, Siri Shastry4, E Jennifer Edelman5.   

Abstract

The COVID-19 pandemic has resulted in unparalleled societal disruption with wide ranging effects on individual liberties, the economy, and physical and mental health. While no social strata or population has been spared, the pandemic has posed unique and poorly characterized challenges for individuals with opioid use disorder (OUD). Given the pandemic's broad effects, it is helpful to organize the risks posed to specific populations using theoretical models. These models can guide scientific inquiry, interventions, and public policy. Models also provide a visual image of the interplay of individual-, network-, community-, structural-, and pandemic-level factors that can lead to increased risks of infection and associated morbidity and mortality for individuals and populations. Such models are not unidirectional, in that actions of individuals, networks, communities and structural changes can also affect overall disease incidence and prevalence. In this commentary, we describe how the social ecological model (SEM) may be applied to describe the theoretical effects of the COVID-19 pandemic on individuals with opioid use disorder (OUD). This model can provide a necessary framework to systematically guide time-sensitive research and implementation of individual-, community-, and policy-level interventions to mitigate the impact of the COVID-19 pandemic on individuals with OUD.

Entities:  

Keywords:  COVID-19; Coronavirus (COVID-19) pandemic; People who use drugs; Social ecological model

Mesh:

Year:  2021        PMID: 33413619      PMCID: PMC7789072          DOI: 10.1186/s13722-020-00210-w

Source DB:  PubMed          Journal:  Addict Sci Clin Pract        ISSN: 1940-0632


  8 in total

Review 1.  Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration.

Authors:  Sandro Galea; David Vlahov
Journal:  Public Health Rep       Date:  2002       Impact factor: 2.792

2.  Low rates of hepatitis A and B vaccination in patients with chronic hepatitis C at an urban methadone maintenance program.

Authors:  Uriel R Felsen; Dawn A Fishbein; Alain H Litwin
Journal:  J Addict Dis       Date:  2010-10

3.  COVID-19 in Prisons and Jails in the United States.

Authors:  Laura Hawks; Steffie Woolhandler; Danny McCormick
Journal:  JAMA Intern Med       Date:  2020-08-01       Impact factor: 21.873

4.  Correction: COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States.

Authors:  Quan Qiu Wang; David C Kaelber; Rong Xu; Nora D Volkow
Journal:  Mol Psychiatry       Date:  2021-01       Impact factor: 15.992

5.  Opioid Use Disorder and COVID-19: Biological Plausibility for Worsened Outcomes.

Authors:  Jonathan Schimmel; Alex F Manini
Journal:  Subst Use Misuse       Date:  2020-07-12       Impact factor: 2.164

6.  Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemics.

Authors:  Stefan Baral; Carmen H Logie; Ashley Grosso; Andrea L Wirtz; Chris Beyrer
Journal:  BMC Public Health       Date:  2013-05-17       Impact factor: 3.295

7.  Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2).

Authors:  Idris E Leppla; Marielle S Gross
Journal:  J Addict Med       Date:  2020 Jul/Aug       Impact factor: 3.702

8.  COVID-19 During the Opioid Epidemic - Exacerbation of Stigma and Vulnerabilities.

Authors:  Wiley D Jenkins; Rebecca Bolinski; John Bresett; Brent Van Ham; Scott Fletcher; Suzan Walters; Samuel R Friedman; Jerel M Ezell; Mai Pho; John Schneider; Larry Ouellet
Journal:  J Rural Health       Date:  2020-06-01       Impact factor: 5.667

  8 in total
  12 in total

1.  Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use Disorder.

Authors:  Lewei Allison Lin; Lan Zhang; Hyungjin Myra Kim; Madeline C Frost
Journal:  Am J Psychiatry       Date:  2022-07-28       Impact factor: 19.242

2.  Psychotherapists' Reports regarding the Impact of the COVID-19 Pandemic on Their Patients: A Cross-National Descriptive Study Based on the Social-Ecological Model (SEM).

Authors:  Yvonne Schaffler; Martin Kuska; Antonia Barke; Bettina K Doering; Katharina Gossmann; Zdenek Meier; Natalia Kascakova; Peter Tavel; Elke Humer; Christoph Pieh; Peter Stippl; Wolfgang Schimböck; Barbara Haid; Thomas Probst
Journal:  Int J Environ Res Public Health       Date:  2022-06-02       Impact factor: 4.614

3.  Big Events theory and measures may help explain emerging long-term effects of current crises.

Authors:  Samuel R Friedman; Pedro Mateu-Gelabert; Georgios K Nikolopoulos; Magdalena Cerdá; Diana Rossi; Ashly E Jordan; Tarlise Townsend; Maria R Khan; David C Perlman
Journal:  Glob Public Health       Date:  2021-04-11

4.  Pharmacists and opioid use disorder care during COVID-19: Call for action.

Authors:  Insaf Mohammad; Dena Berri; Victoria Tutag Lehr
Journal:  J Am Coll Clin Pharm       Date:  2021-11-08

Review 5.  Technology-Based Mental Health Interventions for Domestic Violence Victims Amid COVID-19.

Authors:  Zhaohui Su; Ali Cheshmehzangi; Dean McDonnell; Hengcai Chen; Junaid Ahmad; Sabina Šegalo; Claudimar Pereira da Veiga
Journal:  Int J Environ Res Public Health       Date:  2022-04-03       Impact factor: 3.390

6.  Evaluation of an emergency safe supply drugs and managed alcohol program in COVID-19 isolation hotel shelters for people experiencing homelessness.

Authors:  Thomas D Brothers; Malcolm Leaman; Matthew Bonn; Dan Lewer; Jacqueline Atkinson; John Fraser; Amy Gillis; Michael Gniewek; Leisha Hawker; Heather Hayman; Peter Jorna; David Martell; Tiffany O'Donnell; Helen Rivers-Bowerman; Leah Genge
Journal:  Drug Alcohol Depend       Date:  2022-04-07       Impact factor: 4.852

7.  Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis.

Authors:  Suzan M Walters; Rebecca S Bolinski; Ellen Almirol; Stacy Grundy; Scott Fletcher; John Schneider; Samuel R Friedman; Lawrence J Ouellet; Danielle C Ompad; Wiley Jenkins; Mai T Pho
Journal:  Addict Sci Clin Pract       Date:  2022-04-25

8.  Introduction to the Special Series: National Drug Abuse Treatment Clinical Trials Network and the Opioid Use Disorder Care Continuum-20 years of research informing practice.

Authors:  Andrew J Saxon; E Jennifer Edelman
Journal:  Addict Sci Clin Pract       Date:  2022-02-02

Review 9.  The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review.

Authors:  Karen Alexander; Monika Pogorzelska-Maziarz; Angela Gerolamo; Nadia Hassen; Erin L Kelly; Kristin L Rising
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-08-09

10.  The Family Check-Up Online: A Telehealth Model for Delivery of Parenting Skills to High-Risk Families With Opioid Use Histories.

Authors:  Elizabeth A Stormshak; Jordan M Matulis; Whitney Nash; Yijun Cheng
Journal:  Front Psychol       Date:  2021-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.